Literature DB >> 9490996

Conjunctivitis.

G L Morrow1, R L Abbott.   

Abstract

Conjunctivitis refers to any inflammatory condition of the membrane that lines the eyelids and covers the exposed surface of the sclera. It is the most common cause of "red eye". The etiology can usually be determined by a careful history and an ocular examination, but culture is occasionally necessary to establish the diagnosis or to guide therapy. Conjunctivitis is commonly caused by bacteria and viruses. Neisseria infection should be suspected when severe, bilateral, purulent conjunctivitis is present in a sexually active adult or in a neonate three to five days postpartum. Conjunctivitis caused by Chlamydia trachomatis or Neisseria gonorrhoeae requires aggressive antibiotic therapy, but conjunctivitis due to other bacteria is usually self-limited. Chronic conjunctivitis is usually associated with blepharitis, recurrent styes or meibomianitis. Treatment requires good eyelid hygiene and the application of topical antibiotics as determined by culture. Allergic conjunctivitis is distinguished by severe itching and allergen exposure. This condition is generally treated with topical antihistamines, mast-cell stabilizers or anti-inflammatory agents.

Entities:  

Mesh:

Year:  1998        PMID: 9490996

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  17 in total

Review 1.  Diagnosis of viral and chlamydial keratoconjunctivitis: which laboratory test?

Authors:  E M Elnifro; R J Cooper; P E Klapper; A S Bailey; A B Tullo
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

Review 2.  Topical antibiotics for acute bacterial conjunctivitis: a systematic review.

Authors:  A Sheikh; B Hurwitz
Journal:  Br J Gen Pract       Date:  2001-06       Impact factor: 5.386

3.  Weep, oh mine eyes: an outbreak of bacterial conjunctivitis.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2002-05-14       Impact factor: 8.262

Review 4.  Common eye infections.

Authors:  Stephanie Watson; Maria Cabrera-Aguas; Pauline Khoo
Journal:  Aust Prescr       Date:  2018-06-01

5.  Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.

Authors:  Timothy L Comstock; Michael R Paterno; Dale W Usner; Michael E Pichichero
Journal:  Paediatr Drugs       Date:  2010-04-01       Impact factor: 3.022

6.  3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children.

Authors:  Isabelle Cochereau; Amel Meddeb-Ouertani; Moncef Khairallah; Abdelouahed Amraoui; Khalid Zaghloul; Mihai Pop; Laurent Delval; Pascale Pouliquen; Radhika Tandon; Prashant Garg; Pablo Goldschmidt; Tristan Bourcier
Journal:  Br J Ophthalmol       Date:  2006-10-18       Impact factor: 4.638

Review 7.  Conjunctivitis: a systematic review of diagnosis and treatment.

Authors:  Amir A Azari; Neal P Barney
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

8.  Oral Chlamydia trachomatis in patients with established periodontitis.

Authors:  S G Reed; D E Lopatin; B Foxman; B A Burt
Journal:  Clin Oral Investig       Date:  2000-12       Impact factor: 3.573

9.  Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis.

Authors:  Timothy L Comstock; Paul M Karpecki; Timothy W Morris; Jin-Zhong Zhang
Journal:  Clin Ophthalmol       Date:  2010-04-26

10.  Ocular myasis and associated mucopurulent conjuctivitis acquired occupationally: A case study.

Authors:  K Jayaprakash; A Karthikeyan
Journal:  Indian J Occup Environ Med       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.